v3.26.1
Financial Instruments (Tables)
9 Months Ended
May 31, 2026
Investments, All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents and Restricted Cash and Cash Equivalents The following provides a reconciliation of cash and restricted cash as presented on our condensed consolidated statements of cash flows as of the respective periods:

 

 

 

May 31,

 

($ in thousands)

 

2026

 

 

2025

 

Cash and cash equivalents

 

$

155,020

 

 

$

203,497

 

Restricted cash and cash equivalents

 

 

2,973

 

 

 

39,928

 

Total cash and restricted cash

 

$

157,993

 

 

$

243,425

 

Schedule of Fair Value Measurements

The following summarizes our cash and cash equivalents, restricted cash and cash equivalents and marketable securities by financial instrument category as of the respective periods:

 

 

May 31, 2026

 

($ in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Cash and Cash
Equivalents
(1)

 

 

Current
Marketable
Securities

 

 

Noncurrent
Marketable
Securities

 

Cash

 

$

42,005

 

 

$

 

 

$

 

 

$

42,005

 

 

$

42,005

 

 

$

 

 

$

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

77,144

 

 

 

 

 

 

 

 

 

77,144

 

 

 

77,144

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

24,207

 

 

 

 

 

 

(1

)

 

 

24,206

 

 

 

7,981

 

 

 

16,225

 

 

 

 

Level 2:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. agency securities

 

 

18,498

 

 

 

 

 

 

(11

)

 

 

18,487

 

 

 

 

 

 

 

 

 

18,487

 

Commercial paper

 

 

85,784

 

 

 

 

 

 

(1

)

 

 

85,783

 

 

 

30,863

 

 

 

54,920

 

 

 

 

Corporate debt securities

 

 

21,812

 

 

 

31

 

 

 

(28

)

 

 

21,815

 

 

 

 

 

 

3,906

 

 

 

17,909

 

Total

 

$

269,450

 

 

$

31

 

 

$

(41

)

 

$

269,440

 

 

$

157,993

 

 

$

75,051

 

 

$

36,396

 

 

 

 

August 31, 2025

 

($ in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Cash and Cash
Equivalents
(1)

 

 

Current
Marketable
Securities

 

 

Noncurrent
Marketable
Securities

 

Cash

 

$

129,113

 

 

$

 

 

$

 

 

$

129,113

 

 

$

129,113

 

 

$

 

 

$

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

39,574

 

 

 

 

 

 

 

 

 

39,574

 

 

 

39,574

 

 

 

 

 

 

 

Level 2:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

26,070

 

 

 

71

 

 

 

(19

)

 

 

26,122

 

 

 

4,314

 

 

 

9,005

 

 

 

12,803

 

Total

 

$

194,757

 

 

$

71

 

 

$

(19

)

 

$

194,809

 

 

$

173,001

 

 

$

9,005

 

 

$

12,803

 

 

(1)
Cash and cash equivalents includes restricted cash and cash equivalents.